Certified by Founder Lodge
Qiming Venture Partners
China - Shanghai
INVESTOR
1 Disclosed Funding Rounds $32,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, Seattle, Boston, and the San Francisco Bay Area.
Curr
| Company | Date | Round | Raised |
|---|---|---|---|
 Epigenic Therapeutics |
August, 30 ,2023 | Series A | $32,000,000 |
 AusperBio |
July, 16 ,2024 | Series A | $37,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
